Episode 4: Valbenazine

Episode 4: Valbenazine

Psychopharmacology
Today’s episode is the first in my new Medication Minute series of this podcast. These shorter episodes will feature information regarding a specific subset of psychiatric medication management; anything from a new drug that is available to important side effects of a medication. On today’s episode, I want to discuss a new medication called valbenazine (Ingrezza), which recently became the first FDA-approved drug to treat tardive dyskinesia. References Meyer, Jonathan M., MD. "Valbenazine for Tardive Dyskinesia." Current Psychiatry 16.5 (May 2017): 40-45. Print. Hauser, Robert A., MD, MBA, and Et Al. "KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia." American Journal of Psychiatry. N.p., 21 Mar. 2017. Web. 14 July 2017. Gelenberg, Alan J., MD. "Valbenazine (Ingrezza): The First Drug Approved to Treat TD."…
Read More
Episode 3: Assessment of Safety in an Emergency Setting

Episode 3: Assessment of Safety in an Emergency Setting

Assessment
On today’s episode, our topic of discussion is the assessment of patient safety in an emergency setting. This is a topic that I think is a good review at any stage in our training, as safety of our patient’s while in a crisis should be our foremost concern. This will be a good review for residents who are currently taking call in an emergency department setting, as well as psychiatrists working in these positions. References Palmer, Brian A. “The Lifetime Risk of Suicide in Schizophrenia.” Archives of General Psychiatry 62 (2005): 247-253. Pirkis J, Burgess P. “Suicide and Recency of Health Care Contacts: A Systematic Review.” Br J Psychiatry. 1998: 173(6)462-474. Lund-Sorensen, Helene. “A nationwide cohort study of the association between hospitalization with infection and risk of death by suicide.”…
Read More
Episode 2: Sleep-Wake Disorders

Episode 2: Sleep-Wake Disorders

Diagnoses
On today’s episode we will be discussing sleep-wake disorders. We will first discuss a quick overview of normal sleep architecture, as well as the tools available for evaluation of sleep. We will then delve into the specifics of the various sleep-wake disorders, as classified by the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, including insomnia disorder, hypersomnolence disorder, narcolepsy, breathing-related sleep disorders, circadian rhythm sleep-wake disorders, and we will also touch briefly on non-REM sleep arousal disorders, nightmare disorder, REM sleep behavior disorder, restless legs syndrome, and substance/medication-induced sleep disorder. Please click here to view an EEG recording of the various sleep stages, as discussed in the episode. Please click here to view and print my sleep hygiene handout for patients. This handout can be used free-of-charge for printing…
Read More
Episode 1: Medication-Induced Movement Disorders

Episode 1: Medication-Induced Movement Disorders

Psychopharmacology
On today’s episode, we will be discussing medication-induced movement disorders. This is a broad topic, in which we find that many of the medications we use to help our patients not only in the mental health field, but in the general medical field as well, are capable of causing abnormal movements that range from embarrassing and uncomfortable for the patient to dangerous medical emergencies. Because of the breadth of this topic, we will be discussing mainly the induction of movement disorders caused most frequently by psychiatric medications, mainly neuroleptic agents. Drug-Induced Movement Disorders was a very helpful resource in researching for this episode. If you are interested in further information regarding drug-induced movement disorders, click here to view and purchase: Please click here to view video of rabbit syndrome, as discussed…
Read More